Sort
8,912 grants matching “sars cov 2”
COVID-19 Serosurveys and Vaccine Study Site Preparations
$390,420Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Animal Core
$390,290Stephen Mark Tompkins · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AI
Therapeutic Monoclonal Antibodies Inhibiting Proteases of Biomedical Importance
$390,000Xin Ge · University Of Texas Hlth Sci Ctr Houston · R35 · FY2021 · GM
Therapeutic Monoclonal Antibodies Inhibiting Proteases of Biomedical Importance
$390,000Xin Ge · University Of Texas Hlth Sci Ctr Houston · R35 · FY2025 · GM
Therapeutic Monoclonal Antibodies Inhibiting Proteases of Biomedical Importance
$390,000Xin Ge · University Of Texas Hlth Sci Ctr Houston · R35 · FY2023 · GM
Therapeutic Monoclonal Antibodies Inhibiting Proteases of Biomedical Importance
$390,000Xin Ge · University Of Texas Hlth Sci Ctr Houston · R35 · FY2024 · GM
Therapeutic Monoclonal Antibodies Inhibiting Proteases of Biomedical Importance
$390,000Xin Ge · University Of Texas Hlth Sci Ctr Houston · R35 · FY2022 · GM
Purinergic modulation of the autoimmune vascular phenotype
$390,000Jason Knight · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
Targeting TMPRSS2 expression as a therapy for coronavirus infection and replication
$390,000Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2020 · CA
Advancing Methods in Infectious Diseases Models: Incorporating Structural Causes
$389,962Nadia Natasha Abuelezam · Boston College · R35 · FY2023 · GM
Advancing Methods in Infectious Diseases Models: Incorporating Structural Causes
$389,962Nadia Natasha Abuelezam · Boston College · R35 · FY2022 · GM
Advancing Methods in Infectious Diseases Models: Incorporating Structural Causes
$389,962Nadia Natasha Abuelezam · Boston College · R35 · FY2021 · GM
Advancing Methods in Infectious Diseases Models: Incorporating Structural Causes
$389,962Nadia Natasha Abuelezam · Boston College · R35 · FY2024 · GM
Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's Disease
$389,934Michael G Rosenfeld · University Of California, San Diego · R01 · FY2025 · AG
Real-time structural and functional studies of SARS-CoV-2 spike proteins
$389,821Yi-Chih Lin · University Of Texas At Austin · R35 · FY2024 · GM
Real-time structural and functional studies of SARS-CoV-2 spike proteins
$389,820Yi-Chih Lin · University Of Texas At Austin · R35 · FY2025 · GM
Real-time structural and functional studies of SARS-CoV-2 spike proteins
$389,820Yi-Chih Lin · University Of Texas At Austin · R35 · FY2023 · GM
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
$389,802Raif Salim Geha · Boston Children'S Hospital · R01 · FY2020 · AI
Hawaii Biotech COVID-19 Response to PA-18-591
$389,739David E. Clements · Hawaii Biotech, Inc. · R44 · FY2020 · AI
Virus-Like Particle Vaccine for SARS-CoV
$389,425Raphael Paul Viscidi · Johns Hopkins University · R01 · FY2006 · AI
CoVPN 5002: SARS-CoV-2 Prevalence Study -Supplement Request
$389,142Deborah J Donnell · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Repurposing of Universal and Immunogenic MultiTEP Platform Designed for AD to Develop SARS-CoV-2 Multiepitope Vaccine
$389,064Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2020 · AG
Weather extremes, natural disasters, and health outcomes among vulnerable older adults: New improvements on exposure assessment, disparity identification, and risk communication strategies
$389,043Shao Lin · State University Of New York At Albany · R01 · FY2023 · AG
Coronavirus RNA synthesis by multicomponent protein machines
$389,042Robert N Kirchdoerfer · University Of Wisconsin-Madison · R01 · FY2025 · AI
Coronavirus RNA synthesis by multicomponent protein machines
$389,042Robert N Kirchdoerfer · University Of Wisconsin-Madison · R01 · FY2023 · AI